<DOC>
	<DOCNO>NCT00046878</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . O ( 6 ) -benzylguanine may increase effectiveness carmustine make tumor cell sensitive drug . PURPOSE : Phase II trial study effectiveness combine carmustine O ( 6 ) -benzylguanine treat patient newly diagnose supratentorial glioblastoma multiforme .</brief_summary>
	<brief_title>Carmustine O ( 6 ) -Benzylguanine Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : - Determine activity carmustine O6-benzylguanine patient newly diagnose supratentorial glioblastoma multiforme require immediate radiotherapy . - Determine toxicity regimen patient . OUTLINE : Patients receive O6-benzylguanine IV 1 hour follow approximately 1 hour later carmustine IV 1 hour day 1 . Treatment repeat every 6 week maximum 3 course absence disease progression unacceptable toxicity . Patients refer radiotherapy . Patients demonstrate tumor response completion third course chemotherapy receive 6 additional course completion radiotherapy . PROJECTED ACCRUAL : A total 19-36 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<mesh_term>O ( 6 ) -benzylguanine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm newly diagnose supratentorial glioblastoma multiforme require immediate radiotherapy Measurable residual disease contrastenhanced MRI CT scan ( patient medical contraindication MRI ) baseline scan obtain corticosteroid dose patient receive day treatment PATIENT CHARACTERISTICS : Age 18 Performance status Karnofsky 60100 % Life expectancy Not specify Hematopoietic Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hemoglobin great 10 g/dL Hepatic Bilirubin normal SGOT great 2.5 time upper limit normal Renal Creatinine great 1.5 mg/dL BUN great 25 mg/dL Pulmonary DLCO great 75 % predict Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 2 month study PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy See Disease Characteristics Concurrent corticosteroid allow stable dose 3 day study Radiotherapy See Disease Characteristics Surgery No 28 day since prior surgical resection biopsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>